Patexia Research

Case number 1:21-cv-01067

Lawsuits

Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al > Summary

Court Case Number 1:21-cv-01067

Filing Date Jul 23, 2021

Court Delaware District Court

Status Unknown

JudgesMaryellen Noreika

Plaintiff

Neurocrine Biosciences

Defendant

2

Crystal Pharmatech Co. Ltd.

Plaintiff Attorneys

11

Neurocrine Biosciences
Attorney Name: Steven J. Balick
Ashby & Geddes

Neurocrine Biosciences
Attorney Name: Lauren J. Robinson
Finnegan, Henderson, Farabow, Garrett & Dunner

Neurocrine Biosciences
Attorney Name: Andrew C. Mayo
Ashby & Geddes

Neurocrine Biosciences
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner

Neurocrine Biosciences
Attorney Name: Jeanette M. Roorda
Finnegan, Henderson, Farabow, Garrett & Dunner

Neurocrine Biosciences
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner

Attorney Name: Erin McGeehan Sommers

Neurocrine Biosciences
Attorney Name: Erin McGeehan Sommers

Neurocrine Biosciences
Attorney Name: James B. Monroe

Neurocrine Biosciences
Attorney Name: Jeanette M. Roorda

Neurocrine Biosciences
Attorney Name: Lauren J. Robinson

Defendant Attorneys

11

Crystal Pharmatech Co. Ltd.
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Elizabeth M. Crompton
Parker Poe Adams & Bernstein LLP

Crystal Pharmatech Co. Ltd.
Attorney Name: Cecil Kyle Musgrove
Parker Poe Adams & Bernstein LLP

Crystal Pharmatech Co. Ltd.
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Ronald P. Golden III
Bayard, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Scott A. Cunning II
Parker Poe Adams & Bernstein LLP

Attorney Name: Cecil Kyle Musgrove

Crystal Pharmatech Co. Ltd.
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Cecil Kyle Musgrove

Crystal Pharmatech Co. Ltd.
Attorney Name: Elizabeth M. Crompton

Sandoz
Attorney Name: Stephen B. Brauerman
Bayard, P.A.

Counter Defendant

6

Neurocrine Biosciences
Attorney Name: Steven J. Balick
Ashby & Geddes

Neurocrine Biosciences
Attorney Name: Andrew C. Mayo
Ashby & Geddes

Neurocrine Biosciences
Attorney Name: Steven J. Balick
Ashby & Geddes

Neurocrine Biosciences
Attorney Name: Andrew C. Mayo
Ashby & Geddes

Neurocrine Biosciences
Attorney Name: Steven J. Balick
Ashby & Geddes

Neurocrine Biosciences
Attorney Name: Andrew C. Mayo
Ashby & Geddes

Counter Claimant

8

Crystal Pharmatech Co. Ltd.
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Ronald P. Golden III
Bayard, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Ronald P. Golden III
Bayard, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Ronald P. Golden III
Bayard, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Ronald P. Golden III
Bayard, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: Ronald P. Golden III
Bayard, P.A.

Crystal Pharmatech Co. Ltd.
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
10952997	Methods for the administration of certain VMAT2 inhibitors	Mar 23, 2021
10940141	Methods for the administration of certain VMAT2 inhibitors	Mar 9, 2021
10919892	Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)	Feb 16, 2021
10912771	Methods for the administration of certain VMAT2 inhibitors	Feb 9, 2021
10906902	Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)	Feb 2, 2021
10906903	Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate)	Feb 2, 2021
10874648	Methods for the administration of certain VMAT2 inhibitors	Dec 29, 2020
10857137	Methods for the administration of certain VMAT2 inhibitors	Dec 8, 2020
10857148	Methods for the administration of certain VMAT2 inhibitors	Dec 8, 2020
10851103	Valbenazine salts and polymorphs thereof	Dec 1, 2020
10851104	Valbenazine salts and polymorphs thereof	Dec 1, 2020
10844058	Valbenazine salts and polymorphs thereof	Nov 24, 2020
10065952	Valbenazine salts and polymorphs thereof	Sep 4, 2018